Published in Transplantation on March 01, 1971
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39
A new micromethod for evaluating lymphocyte responses to phytohemagglutinin: quantitative analysis of the function of thymus-dependent cells. Proc Natl Acad Sci U S A (1972) 1.24
Cell-mediated immunity in diabetes mellitus. Clin Exp Immunol (1974) 1.08
Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. J Epidemiol Community Health (1980) 1.06
Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes. Clin Exp Immunol (1976) 0.98
Thymus-dependent lymphocytes in human bone marrow. J Clin Invest (1975) 0.96
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. Clin Exp Immunol (1975) 0.92
In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis. Clin Exp Immunol (1975) 0.85
Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts. Clin Exp Immunol (1975) 0.84
Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations. Clin Exp Immunol (1977) 0.84
Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence. Can Med Assoc J (1975) 0.84
Third party mixed-leukocyte culture test: a potential new method of histocompatibility testing. Proc Natl Acad Sci U S A (1972) 0.83
Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation. J Clin Pathol (1992) 0.79
Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg. Can Med Assoc J (1975) 0.78
Epidermal growth factor: in vivo ocular studies. Trans Am Ophthalmol Soc (1980) 0.78
Lymphocytotoxins and mixed leucocyte culture blocking factor activity in the plasma of uraemic patients undergoing haemodialysis. Clin Exp Immunol (1975) 0.77
Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. Br Med J (Clin Res Ed) (1982) 0.75
Inhibition of lymphocyte growth by Ulex seed extracts (USE). Immunology (1981) 0.75
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg. Can Med Assoc J (1975) 1.45
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
HLA matching assessed from early graft function. Transplant Proc (1987) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA (1969) 1.38
Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37
HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. Arch Neurol (1980) 1.37
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35
Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34
Cross-reactions between streptococcal M proteins and human transplantation antigens. Science (1970) 1.33
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol (1993) 1.32
Serotyping for homotransplantation. IX. Evaluation of leukocyte antigen matching with the clinical course and rejection types. Transplantation (1967) 1.32
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med (1968) 1.31
Close genetic linkage between diabetes mellitus and kidd blood group. Lancet (1981) 1.30
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation (1970) 1.28
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics (1982) 1.25
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med (1991) 1.23
HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet (1979) 1.23
De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant (2011) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Public determinants of HLA indicated by pregnancy antibodies. Transplantation (1986) 1.20
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med (2000) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Induction of high kidney graft survival rate by multiple transfusion. Lancet (1981) 1.18
HL-A haplotypes of 32 diseases. Transplant Rev (1975) 1.18
HLA-A2 and type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia (1981) 1.16
Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16
Multiple sclerosis and high incidence of a B lymphocyte antigen. Science (1976) 1.14
HL-A W27 in psoriatic arthropathy. Arthritis Rheum (1975) 1.14
Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti-B-cell alloantisera. J Natl Cancer Inst (1977) 1.14
HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease. N Engl J Med (1974) 1.13
Leucocyte antigens and disease. I. Association of HL-A2 and chronic glomerulonephritis. Br Med J (1969) 1.12
Effect of splenectomy on human renal transplants. Transplantation (1973) 1.12
Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplantation (1968) 1.11
Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc (1977) 1.10